|Year : 1995 | Volume
| Issue : 2 | Page : 84--88
Managing recurrent genital herpes with acyclovir
Seventy five patients of recurrent genital herpes (RGH) treated with oral or topical acyclovir and placebo were compared and followed for periods ranging 4 to 8 years in a prospective study. Oral acyclovir definitely helps RGH patients; it shortens healing time; postpones recurrences and instills confidence in the patients. There is sufficient evidence that RGH dies a natural death with time as seen after 8 years follow up in placebo group patients. Topical use of acyclovir cream is not as useful as believed.
T R Bedi
Source of Support: None, Conflict of Interest: None
[FULL TEXT] [PDF Not available]*